Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep

1995, ANZCCART-News, 8, 1

1989, Perit Dial Int, 9, 95, 10.1177/089686088900900203

1991, Contrib Nephrol, 88, 136, 10.1159/000419523

2001, J Pharmacol Exp Ther, 298, 820

2001, Pharm Res (NY), 18, 1620, 10.1023/A:1013046918190

10.1002/(SICI)1520-6017(200002)89:2<168::AID-JPS4>3.0.CO;2-Q

1988, Pharm Res (NY), 5, 156, 10.1023/A:1015960806202

10.1016/0049-3848(87)90391-4

1990, Clin Pharmacol Ther, 47, 557, 10.1038/clpt.1990.76

Gibaldi M and Perrier D (1982) Pharmacokinetics. Marcel Dekker, Inc., New York.

10.1038/clpt.1991.210

1994, Eur J Clin Pharmacol, 46, 333

1989, Contrib Nephrol, 76, 106, 10.1159/000417886

1997, J Pharmacol Exp Ther, 283, 520

1976, Fed Proc, 35, 1863

1991, Clin Pharmacokinet, 20, 99, 10.2165/00003088-199120020-00002

2003, Pharm Res (NY), 20, 1156, 10.1023/A:1025036611949

1997, Pharm Res (NY), 14, 1621, 10.1023/A:1012142704924

10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P

10.1016/S0169-409X(01)00153-3

10.1124/jpet.102.047191

10.1177/0091270004268411

1990, Br J Clin Pharmacol, 29, 709, 10.1111/j.1365-2125.1990.tb03692.x

1990, Pharm Res (NY), 7, 167, 10.1023/A:1015880819328

10.1002/jps.2600840619

10.1002/(SICI)1099-081X(199905)20:4<217::AID-BDD177>3.0.CO;2-6